SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-235008
Filing Date
2018-08-01
Accepted
2018-08-01 16:41:57
Documents
6
Period of Report
2018-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d594239d8k.htm 8-K 19249
2 EX-1.1 d594239dex11.htm EX-1.1 176867
3 EX-5.1 d594239dex51.htm EX-5.1 4971
4 EX-99.1 d594239dex991.htm EX-99.1 10416
5 GRAPHIC g594239001.jpg GRAPHIC 2877
6 GRAPHIC g594239002.jpg GRAPHIC 4271
  Complete submission text file 0001193125-18-235008.txt   223091
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 18985334
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1